Lilly’s Cymbalta Wins FDA Approval For Major Depression Maintenance Therapy

The battle with Wyeth’s competing SNRI Effexor XR for new indications continues; Cymbalta could see an indication for fibromyalgia in 2008.

More from Archive

More from Pink Sheet